Live feed
Filing
SC 13D/A
SC 13D/A0001144204-19-019693·KalVista Pharmaceuticals, Inc.
Schedule 13D ownership disclosure
KalVista Pharmaceuticals Inc
Security class unavailable · CUSIP: 483497103
Event date: 2019-04-11
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 958,570
- Percent of class
- 5.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001144204-19-019693
- Form type
- SC 13D/A
- Filer
- KalVista Pharmaceuticals, Inc.
- CIK
- CIK 1348911
- Filed
- Apr 15, 2019
- Reporting period
- Apr 11, 2019
- Description
- Schedule 13D beneficial ownership